Reynaldo Jr. Carubio, Bao-Hsiang Wang, Marion B. Ansorge-Schumacher
{"title":"Reaction Engineering for Asymmetric R-/S-PAC Synthesis With Ephedrine or Pseudoephedrine Dehydrogenase in Pickering Emulsion","authors":"Reynaldo Jr. Carubio, Bao-Hsiang Wang, Marion B. Ansorge-Schumacher","doi":"10.1002/elsc.202400069","DOIUrl":null,"url":null,"abstract":"<p>The synthesis of enantiopure α-hydroxy ketones, particularly <i>R</i>- and <i>S</i>-phenylacetylcarbinol (PAC), represents an important process in the pharmaceutical industry, serving as a pivotal step in the production of drugs. Recently, two novel enzymes, ephedrine dehydrogenase (EDH) and pseudoephedrine dehydrogenase (PseDH), have been described. These enzymes enable the specific reduction of 1-phenyl-1,2-propanedione (PPD) to <i>R</i>-PAC and <i>S</i>-PAC, respectively. In this study, we transferred these enzymes into Pickering emulsions, which is an attractive reaction set-up for large-scale synthesis. The bioactive w/o Pickering emulsion (bioactive Pickering emulsion [BioPE]), in which methyl <i>tert</i>-butyl ether served as the continuous phase, was stabilized by silica nanoparticles. Formate dehydrogenase from <i>Rhodococcus jostii</i> was utilized for cofactor regeneration. Given the considerable complexity of the BioPE, this reaction system underwent a first-time application of design of experiment (DOE) for systematic engineering. A definitive screening design was employed to identify significant factors affecting space-time yield (STY) and conversion. Response surface methodology was used to optimize the conditions, resulting in the observation of a high STY of 4.2 g L⁻¹ h⁻¹ and a conversion of 83.2% for BioPE with EDH, and an STY of 4.4 g L⁻¹ h⁻¹ and a conversion of 64.5% for BioPE with PseDH.</p>","PeriodicalId":11678,"journal":{"name":"Engineering in Life Sciences","volume":"25 2","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/elsc.202400069","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Engineering in Life Sciences","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/elsc.202400069","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The synthesis of enantiopure α-hydroxy ketones, particularly R- and S-phenylacetylcarbinol (PAC), represents an important process in the pharmaceutical industry, serving as a pivotal step in the production of drugs. Recently, two novel enzymes, ephedrine dehydrogenase (EDH) and pseudoephedrine dehydrogenase (PseDH), have been described. These enzymes enable the specific reduction of 1-phenyl-1,2-propanedione (PPD) to R-PAC and S-PAC, respectively. In this study, we transferred these enzymes into Pickering emulsions, which is an attractive reaction set-up for large-scale synthesis. The bioactive w/o Pickering emulsion (bioactive Pickering emulsion [BioPE]), in which methyl tert-butyl ether served as the continuous phase, was stabilized by silica nanoparticles. Formate dehydrogenase from Rhodococcus jostii was utilized for cofactor regeneration. Given the considerable complexity of the BioPE, this reaction system underwent a first-time application of design of experiment (DOE) for systematic engineering. A definitive screening design was employed to identify significant factors affecting space-time yield (STY) and conversion. Response surface methodology was used to optimize the conditions, resulting in the observation of a high STY of 4.2 g L⁻¹ h⁻¹ and a conversion of 83.2% for BioPE with EDH, and an STY of 4.4 g L⁻¹ h⁻¹ and a conversion of 64.5% for BioPE with PseDH.
期刊介绍:
Engineering in Life Sciences (ELS) focuses on engineering principles and innovations in life sciences and biotechnology. Life sciences and biotechnology covered in ELS encompass the use of biomolecules (e.g. proteins/enzymes), cells (microbial, plant and mammalian origins) and biomaterials for biosynthesis, biotransformation, cell-based treatment and bio-based solutions in industrial and pharmaceutical biotechnologies as well as in biomedicine. ELS especially aims to promote interdisciplinary collaborations among biologists, biotechnologists and engineers for quantitative understanding and holistic engineering (design-built-test) of biological parts and processes in the different application areas.